IN THIS ISSUE COMMENTARY Comparing Inhaled Aztreonam to Tobramycin Cost Effectiveness of Aztreonam Lysine Inhaled Tobramycin Affected by Chronic Azithromycin Use AZLI Use: Three Year Prevalence Changes Comparing Colistimethate Sodium Dry Powder to Inhaled Tobramycin Program Directors
نویسندگان
چکیده
Pseudomonas aeruginosa colonization of the cystic fibrosis airway requires chronic therapy with inhaled antibiotics for nearly all patients. Clinician options in the US, however, are limited to tobramycin nebulizer solution (TNS) and aztreonam for inhalation solution (AZLI); in the EU and many other parts of the world, colistimethate and colistimethate dry powder for inhalation (CDPI) are also available.
منابع مشابه
Ciprofloxacin dry powder inhaler in cystic fibrosis.
Correspondence to Professor J Stuart Elborn; [email protected] Inhaled antibiotics are the backbone of care for people with cystic fibrosis (CF) who have lung infection due to Pseudomonas aeruginosa. They have significantly contributed to the improved quality of life (QOL) and increased survival in people with this disease. The systematic application of antibiotic eradication therapy for new o...
متن کاملTreatment of Pseudomonas and Staphylococcus Bronchopulmonary Infection in Patients with Cystic Fibrosis
The optimal antibiotic regimen is unclear in management of pulmonary infections due to pseudomonas and staphylococcus in cystic fibrosis (CF). We systematically searched all the published literature that has considered the evidence for antimicrobial therapies in CF till June 2013. The key findings were as follows: inhaled antipseudomonal antibiotic improves lung function, and probably the safes...
متن کاملCystic fibrosis microbiology: Advances in antimicrobial therapy.
Much of the improvement in the survival of individuals with cystic fibrosis (CF) is due to advancements in antimicrobial treatments. New aerosolized antibiotic formulations have recently been introduced (such as inhaled aztreonam), and others are in development (inhaled levofloxacin and liposomal amikacin). Licensed dry powder formulations include tobramycin inhalation powder and dry powder col...
متن کاملBronchial Hyperreactivity Related to Inhalation Therapy in Cystic Fibrosis Patients
It is presumed that bronchial hyperreactivity (BHR) can occur with any inhaled agent and may be a reason for discontinuation of inhalation therapy in cystic fibrosis (CF) patients. On the other hand, inhalation of antibiotics is being increasingly used to eradicate or treat infections. This review focuses on identifying the mechanisms of BHR for a better understanding of its impact on inhalatio...
متن کاملRecent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients is caused by biofilm-growing mucoid strains. Biofilms can be prevented by early aggressive antibiotic prophylaxis or therapy, and they can be treated by chronic suppressive therapy. New results from one small trial suggest that addition of oral ciprofloxacin to inhaled tobramycin may reduce lung inflammation. Clinica...
متن کامل